Stay updated on Dapagliflozin Effects on Heart in Diabetes Clinical Trial
Sign up to get notified when there's something new on the Dapagliflozin Effects on Heart in Diabetes Clinical Trial page.

Latest updates to the Dapagliflozin Effects on Heart in Diabetes Clinical Trial page
- Check7 days agoChange DetectedRevision history updated: added v3.5.0 and removed v3.4.3.SummaryDifference0.1%

- Check14 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check21 days agoNo Change Detected
- Check28 days agoNo Change Detected
- Check43 days agoChange DetectedRevision: v3.4.2 is now shown and the prior funding-status notice (v3.4.1) has been removed; no trial data, eligibility criteria, or results were changed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check50 days agoChange DetectedA government funding lapse notice appears on the page, and the revision number has been updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check57 days agoChange DetectedThe changes are minor UI/metadata updates: a glossary toggle is shown, the QC status label now reads 'Last Update Submitted that Met QC Criteria', the 'No FEAR Act Data' note was removed, and the study revision updated from v3.3.4 to v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check71 days agoChange DetectedThe page shows a minor revision update: Revision: v3.3.4 added and Revision: v3.3.3 removed, which does not alter study details or eligibility information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Dapagliflozin Effects on Heart in Diabetes Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dapagliflozin Effects on Heart in Diabetes Clinical Trial page.